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Perinatal asphyxia occurs at an incidence of 1-2% per live births in developed countries, 
and much higher in developing countries. The main consequence of significant perinatal 
asphyxia is neonatal encephalopathy which, if severe enough, may result in death or 
long term neurological disability. Therapeutic hypothermia (TH) has emerged as a 
promising therapy in reducing its mortality and morbidity. Electrolyte abnormalities, 
including hyponatremia, are a common occurrence in neonates with HIE. Possible 
causes of hyponatremia are renal impairment secondary to acute kidney injury and the 
syndrome of inappropriate anti-diuretic hormone (SIADH). Therapeutic hypothermia 
itself has an impact on fluid and electrolyte balance. Serum sodium concentration is 
closely linked to serum osmolality and neuroprotective strategies following brain injuries 
usually include maintaining serum sodium within normal limits to minimize further 
damage. Studies done on adults have shown adverse effects of dysnatremia on 
neurologic outcome following brain injuries. These studies however looked at disease 
entities more common in the adult population. There are very few studies assessing 
dysnatremia in the neonatal population, hence the interest in carrying out this analysis. 
 
Methods 
This retrospective descriptive study is a sub-analysis of a previous prospective study for 
infants who met therapeutic hypothermia criteria after sustaining hypoxic ischemic 
encephalopathy. The infants were treated in the neonatal intensive care unit of the 
Department of Paediatrics and Child Health at the Tygerberg Children’s Hospital 
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between 2008 and 2011. According to the cooling protocol, each infant had serum 
sodium levels measured on three consecutive days during cooling. After discharge the 
neurodevelopmental functional status was assessed during follow-up visits. The primary 
aim of the study was to determine if there is an association between hyponatraemia in 
neonates with HIE who underwent therapeutic hypothermia and neurodevelopmental 
outcome at 12 months of age, as assessed by Bayley Screening tool (BSID - III) 
 
Results  
The patient records search yielded 100 patients from 2008 to 2011.  After excluding 
those who did not meet the inclusion criteria, fifty patients were studied. Twenty-one 
(21/50; 42%) patients had hyponatremic episodes. The remainder (29/50; 58%) were 
normonatremic. None were hypernatremic. Thirty-five (35/50; 70%) were assessed as 
normal at twelve-month follow up, nine (9/50; 18%) as mildly abnormal and 6 (6/50; 
12%) as abnormal. There was no association between neurodevelopmental functional 
status at 12 months and frequency of hyponatremic episodes in the first week of life (p = 
0.444). There was a significant association between number of hyponatremic episodes 
and HIE grade. We found no association between HIE grade and neurodevelopmental 
functional status at 12 months. 
  
Conclusion  
There was no significant association between hyponatremia after hypoxic-ischemic 
encephalopathy and neurodevelopmental outcome at 12 months. There was a positive 
correlation between HIE grade and frequency of hyponatremic episodes.  
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Hypoxic ischemic encephalopathy (HIE) refers to a form of neonatal encephalopathy 
(NE) where the underlying mechanism of brain injury is hypoxia and ischemia. NE in 
turn, as defined by the American Academy of Pediatrics (AAP) and the American 
College of Obstetrics and Gynecology (ACOG), is a clinically defined syndrome of 
disturbed neurological function in the earliest days of life in an infant born at or beyond 
35 weeks of gestation, manifested by a subnormal level of consciousness or seizures, 
and often accompanied by difficulty with initiating and maintaining respiration and 
depression of tone and reflexes.  
 
The definition of HIE has undergone modification over recent years. Previously, terms 
such as birth asphyxia and perinatal asphyxia were broadly applied to all neonates who 
presented with signs and symptoms of neurologic dysfunction, regardless of the 
etiology. With time, it became clear that a wide range of pathologies, both maternal and 
fetal in origin, occurring in the prenatal, perinatal or postnatal period, could manifest as 
NE. The term HIE is now reserved for those neonates who meet strict criteria, showing 
evidence of hypoxia and ischemia as the underlying pathology. 
 
Prior to the advent of therapeutic hypothermia (TH), the management of HIE was limited 
to supportive care only. It was responsible for a large proportion of neonatal mortality as 
well as childhood neurologic morbidities, including cerebral palsy, epilepsy, visual and 
hearing problems. Studies performed on animals elucidated the underlying 
pathophysiologic mechanisms involved in hypoxic-ischemic (HI) injury and allowed 
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more targeted therapeutic strategies to be developed. 
 
4. LITERATURE REVIEW 
 
4.1 PATHOPHYSIOLOGY OF HYPOXIC-ISCHAEMIC INJURY 
 
At the cellular level, HI injury is believed to result in a cascade of events that is initiated 
soon after the initial insult and continues for more than 48 hours afterwards. In the 
absence of oxygen, there is a shift to anaerobic metabolism, which is an inefficient ATP-
depleting pathway. Once ATP is depleted, cellular functions that utilize ATP begin to 
fail, including sodium and potassium trans-cellular ion pumps. This results in loss of 
ionic gradients and widespread depolarisation. Pump failure results in the intracellular 
accumulation of sodium ions, chloride ions and water causing cytotoxic oedema. These 
events that occur at the time of the initial insult are referred to as primary energy  
failure1-3. 
 
Despite the re-establishment of perfusion, the pathologic cascade of events will 
continue for more than 48 hours, characterized by ongoing cellular injury and cell death 
from apoptosis. This secondary process (secondary energy failure) is mediated, 
amongst other substances, by the excitatory neurotransmitter glutamate (excitotoxicity) 
as well as calcium ions, which act as secondary messengers initiating a cascade of 
intracellular events that culminate in neuronal apoptosis. Depletion of ATP and failure of 
membrane pumps during the initial phase results in abnormal accumulation of 
glutamate at the synapses, and also causes an abnormal accumulation of calcium ions 
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in the cytosol. Under glutamate stimulation there is further depolarisation of 
membranes, further disruption of ionic gradients and a vicious cycle is perpetuated. 
Reperfusion also results in the production of an excess of reactive oxygen species that 
cause further cellular injury and inflammation1-3.  
 
4.2 CLINICAL MANIFESTATIONS OF HIE 
 
The clinical manifestations depend on the severity of the HI injury. Infants with mild HI 
injury may have transient behavioral abnormalities such as irritability or drowsiness. The 
neurologic exam may reveal mildly increased tone with brisk reflexes. Infants with 
moderate HI injury may show a depressed level of consciousness with significant 
hypotonia, diminished or absent deep tendon reflexes and abnormal or absent primitive 
reflexes. There may also be seizures and abnormalities in respiration. A typical 
presentation in infants with severe HI injury would include stupor or coma, generalized 
hypotonia with depressed deep tendon reflexes, absent primitive reflexes. There are 
often abnormalities in breathing requiring mechanical ventilation. Seizures and 
autonomic dysfunction, manifesting as abnormalities in heart rate and blood pressure, 
also occur commonly4. 
 
In addition to the neurologic manifestations, infants with HIE often have multi-organ 
involvement. They may have myocardial dysfunction causing hypotension; pulmonary 
hypertension necessitating mechanical ventilation; renal failure leading to significant 
water and electrolyte imbalances; and gastrointestinal involvement which may manifest 
as elevated liver enzymes, delayed gastric emptying and abnormal peristalsis5-7. 
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4.3 STAGING OF HIE  
In 1976, Sarnat and Sarnat formulated a grading system that could be used to classify 
neonates into mild, moderate or severe HIE based on clinical findings. Since then, a 
number of other grading and scoring systems have been introduced8-10, but the Sarnat 
grading system, or modified versions of it, remains the most widely used.  
  
 STAGE 1 
(mild) 
STAGE 2 (moderate) STAGE 3 (severe) 
LEVEL OF 
CONSCIOUSNESS 







































































Seizures None Common/focal or multifocal Uncommon 
EEG Normal/decrea
sed 
Early low voltage continuous 
delta and theta, later 
periodic, seizures focal 1-






DURATION <24h 2-14 days Hours - weeks 
 
TABLE 1: Sarnat staging of neonatal encephalopathy 
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In their original study, Sarnat and Sarnat also found there was an association between 
HIE severity and neurodevelopmental outcome. Infants who had mild HIE had better 
outcomes than those with moderate or severe HIE. This has since been confirmed in 
other studies, using different grading sytems8-10. 
 
4.4   THERAPEUTIC HYPOTHERMIA FOR NEUROPROTECTION 
 
With the understanding that brain injury continues to evolve over hours following the 
initial insult, it was possible to devise therapeutic strategies that target the latent period 
between primary and secondary energy failure in an attempt to prevent or limit this 
ongoing injury process. The initial use of therapeutic hypothermia (TH) in modern 
medicine dates back as far as the 1800s11. Regarding neuroprotection, it was in 1953 
that Bigelow and McBirnie, using canine models, published a study reporting its 
beneficial effect for the brain and the heart during cardiac surgery12. During the ensuing 
30-40 years however, its popularity waned due to the discovery of its deleterious 
effects. Positive data obtained from animal models supporting its benefits later lead to a 
resurgence of interest in the field11. Following prospective studies in adult patients who 
had suffered anoxic brain injury, the American Heart Association published guidelines in 
2002 recommending its use as a treatment modality for out-of-hospital comatose victims 
of cardiac arrest12. 
 
The neuroprotective effects of TH on the immature brain following hypoxic-ischemic 
injury were also demonstrated in several animal studies13. Randomized controlled trials 
in human neonates were conducted from the early 2000s and they repeatedly showed a 
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reduction in the rate of death or neurologic disability following HIE14. Therapeutic 
hypothermia for HIE has since become the standard of care in most developed 
countries15. 
 
The exact mechanisms of neuroprotection by TH continue to be investigated and are 
believed to be multifactorial16. They include, amongst others, suppression of apoptotic 
pathways, suppression of microglial activation and the resultant inflammatory cascades, 
as well as suppression of excitotoxicity16. Although the exact point at which neuronal 
injury becomes irreversible is not known, there is evidence that for TH to be beneficial, 
there is a limited window of opportunity17. The current practice is to initiate TH within 6 
hours of delivery and continue for a total of 72 hours. 
 
In addition to the effects of TH on the brain as described above, lowering the body’s 
temperature to subnormal limits is also associated with some undesirable physiologic 
effects on most systems in the body. Reported effects include sinus bradycardia, 
reduction in cardiac output with some studies reporting hypotension and a need for 
inotropic support18, impaired clotting and immune function, decreased renal blood flow 
and glomerular filtration rate, delayed gastric emptying, disturbances of electrolytes and 
glucose homeostasis18,19. When offered in centres with adequate experience and 
equipment, the risks and adverse effects associated with TH could be minimized in 
favour of benefit. Overshooting of target temperatures, both in the cooling and 
rewarming phases, is also associated with complications and has been associated with 
increased mortality and morbidity18. This may be a problem particularly for the low-
resourced or inexperienced centres. 




4.5    NEUROLOGIC OUTCOME FOLLOWING HIE 
 
Studies done both prior to and following the introduction of TH have shown that certain 
clinical findings, biochemical markers, imaging and electrophysiological findings were 
predictive of neurologic outcomes. Over time, some factors were consistently found to 
be predictive across multiple studies, while others had inconsistent results. Moreover, 
the predictive value of some was altered with the introduction of TH. While they could 
be used in the pre-cooling era, they would not be accurate or would be less predictive 
when used on cooled patients19,20.  
 
The severity of HIE (HIE grade), as determined by scoring systems, has been found to 
be a strong predictive marker of outcome for both cooled and non-cooled infants. It has 
however been found that the predictive value is reduced during TH and that it may be 
more accurate if used after TH has been completed19. The presence of abnormalities on 
amplitude integrated electro-encephalogram (aEEG) and the presence of seizures have 
also been associated with poorer outcomes. Other clinical factors that were commonly 
used for prediction of outcome in the pre-cooling era include APGAR scores, the need 
for prolonged resuscitation, time to establishment of spontaneous respiration and 
severity of metabolic acidosis. These also formed the basis of inclusion criteria in early 
TH trials. Similar to HIE grade, the predictive value of these variables has been altered 
with the introduction of TH20. 
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4.6   HYPONATREMIA 
 
Hyponatremia is defined as a serum sodium concentration of less than 135mmol/L/21. It 
is the most common disorder of body fluid and electrolyte balance and occurs with a 
frequency that varies from 25% to 65% in very ill neonates22. Studies have shown that 
hyponatremia occurs with a higher incidence in neonates with HIE than in healthy 
newborns23,24. In one multi-center randomized trial investigating whether TH improved 
neurodevelopmental outcomes after HIE, Gluckman et al. found that hyponatremia 
occurred both in neonates who underwent TH (49/112 [44%]) and those who had HIE 
but did not undergo TH (46/118 [39%])25. One study in addition, found that the degree of 
hyponatremia was directly proportional to the severity of HIE24. 
  
In the first few days after birth, there is movement of water both from the interstitium as 
well as the intracellular compartment, into the intravascular compartment 26,27. This 
stimulates the release of atrial natriuretic peptide which causes sodium and water 
diuresis and loss of body weight26,27. This means that in a healthy neonate, for the first 
48-72 hours post-delivery, there is a net negative sodium and water balance. Under the 
influence of the renin-aldosterone-angiotensin system, sodium and water balance then 






Stellenbosch University  https://scholar.sun.ac.za
17 
 
4.6.1   CAUSES OF HYPONATREMIA 
 
The etiologies of hyponatremia can be broadly classified into primary water excess or 
primary sodium depletion28,29. Primary water excess can either be the result of excess 
intake of hypotonic fluid (dilutional hyponatremia), or impaired excretion of water. 
Primary sodium depletion is either the result of insufficient intake or excessive loss of 
sodium. A combination of the two mechanisms can also exist in the same patient29. 
 
The majority of the hyponatremia seen in children is thought to be hospital acquired and 
occurring in children who receive hypotonic intravenous fluids30. Hypotonic IV fluids in 
children have been used based mainly on a recommendation made by Holliday and 
Segar more than 50 years ago31. Studies done since then have however showed that 
hypotonic fluids produce hyponatremia in hospitalized children30. Neonates with HIE 
frequently receive intravenous fluid as part of their routine care. Although studies done 
were mostly on older infants and children, this could also be a relevant cause in 
neonates. 
 
Maternal hyponatremia caused by intravenous administration of large volumes of 
hypotonic fluid during labor, or oral ingestion of free water, has been shown to cause 
neonatal hyponatremia29,32. This will be evidenced by hyponatremia in the newborn at, 
or a few hours after birth33. Synthetic oxytocin, used for induction of labor is thought to 
have anti-diuretic properties and when administered to the mother during labor (usually 
in dextrose solutions) can also lead to water intoxication and resultant maternal and 
neonatal hyponatremia34,35. Other medications used by the mother that may result in 
neonatal hyponatremia include diuretics, laxatives, some anti-depressants (eg selective 
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serotonin reuptake inhibitor exposure [SSRI]) and recreational drugs such as 
ecstasy33,36. 
 
Acute kidney injury (AKI) is a common occurrence in babies with HIE and those with 
severe asphyxia are more likely to have renal involvement than those less severely 
affected37. It is believed to be a consequence of an adaptive mechanism during 
hypoxia-ischemia – the diving reflex. This reflex shunts blood away from the skin and 
splanchnic area to the heart, brain and adrenals38. As the kidneys are very sensitive to a 
lack of oxygen, perinatal asphyxia is one of the most frequent causes of AKI in 
neonates37.  
 
The incidence of AKI in neonates with perinatal asphyxia is reported to be 30-56% and 
is thought to be an underestimate due to the lack of a consensus definition of AKI in 
neonates37. One study reported an incidence of approximately 76%39. Another study, 
that looked at the incidence of AKI in neonates with HIE who underwent TH, reported an 
incidence of 38%40. Both non-oliguric and oliguric renal failure occur; there is conflicting 
data from studies regarding which occurs more commonly23,39. AKI may contribute to 
the occurrence of hyponatremia either due to impaired water excretion or impaired 
tubular reabsorption of sodium23,39. 
 
The release of anti-diuretic hormone (ADH) is stimulated by a rise in osmolality, a fall in 
central blood pressure and hypovolemia. Changes in osmolality are sensed by 
osmoreceptors located in the supra-optic nucleus of the hypothalamus, while changes 
in blood pressure and volume status are sensed by baroreceptors located in the cardiac 
atria, aorta and carotid sinus. The two principal actions of ADH are to increase 
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reabsorption of water by the kidneys and vasoconstriction41.  
 
It has been suggested by some authors that the syndrome of inappropriate ADH 
secretion (SIADH) occurs commonly in newborns42. Elevated levels of ADH and 
hyponatremia do occur frequently in sick newborns28,29. It has however been found that 
there are other non-osmotic and non-baroreceptor stimuli that increase the secretion of 
ADH43. In addition, the defense of blood pressure overrides that of tonicity, meaning that 
ADH secretion will continue as long as there is hypovolemia or hypotension, regardless 
of plasma osmolality, serum sodium concentration and volume status44. The non-
osmotic and non-baroreceptor stimuli that have been identified include nausea, 
vomiting, pain, stress, trauma and medications such as opioids and anesthetic agents 
44-46. These findings have several implications. Firstly, neonates are at risk of 
intravascular volume depletion and hypotension47 but the recognition of an inadequate 
intravascular volume can be difficult in children48. It is not known to what extent 
unrecognized baroreceptor stimulation of ADH release contributes to the occurrence of 
water retention and hyponatremia. The proportion of neonates erroneously diagnosed 
with SIADH in the presence of these non-osmotic and non-baroreceptor stimuli to ADH 
secretion is also unknown. Poorly controlled pain in neonatal intensive care units may 
also play a role, as pain is known to cause an immediate increase in ADH concentration 
in urine28. Some authors therefore believe that true inappropriate ADH secretion is 
probably rare in the newborn28. The diagnostic criteria for SIADH include hyponatremia 
with plasma hypotonicity, inappropriately concentrated urine, continued sodium 
excretion, and the exclusion of renal or endocrine disease. Stimuli that produce non-
osmotic release of ADH, such as medications, hypovolemia, hypotension, pain, stress, 
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and nausea, must also be absent49. 
 
The causes of sodium depletion include renal tubular dysfunction such as that seen with 
pyelonephritis, obstructive uropathies, damage caused by nephrotoxic agents and 
medications such as diuretics29. Endocrine disorders, specifically the salt-losing forms of 
congenital adrenal hyperplasia and hypoaldosteronism may also cause hyponatremia29. 
Gastrointestinal diseases causing vomiting and stoma losses are another potential 
cause of sodium depletion29. These pathologies are however not likely to be a cause of 
hyponatremia in the immediate neonatal period. 
 
The implementation of TH may have an impact on the body’s fluid and electrolyte 
status. This was suggested by Prempunpong et al. when they investigated the effect of 
the implementation of TH on fluid balance and incidence of hyponatremia in neonates 
with moderate or severe HIE. They found that neonates who underwent TH had 
increased fluid retention (as evidenced by weight gain) and lower serum sodium 
concentrations than controls. They hypothesized that the application of a cold stimulus 
to the skin results in local vasoconstriction, reduced blood flow and reduced 
transepidermal loss of water50. These neonates are frequently intubated and ventilated, 
which reduces respiratory water loss50, in addition to the other risk factors of impaired 
water excretion, as mentioned previously. The authors acknowledged the limitation of 
not directly measuring the amount of trans-epidermal water loss for the cooled infants. 
Further studies are necessary.  
 
No other cooling studies have investigated the impact of TH on fluid and electrolyte 
balance. Some reported on the incidence of hyponatremia as a secondary outcome and 
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no significant effect of TH was observed between cooled infants and controls50. 
Hypothermia is known to suppress antidiuretic hormone, and in experimental animal 
models cooling was associated with a decrease in renal perfusion and glomerular 
filtration rate51. Meta-analysis of trials that reported the effect of hypothermia on urine 
output however showed no statistically significant difference in the occurence of oliguria 
between cooled and non-cooled infants51,52. 
 
4.6.2   THE EFFECTS OF HYPONATREMIA ON THE BRAIN 
 
As the major cation in the extra-cellular compartment, sodium levels strongly influence 
serum osmolality. Hyponatremia results in a fall of serum osmolality. Without 
compensatory mechanisms, this leads to movement of water from the intravascular 
space into brain cells, down an osmotic gradient, resulting in brain edema53,54. There 
are however adaptive mechanisms in place that counteract brain swelling. The efficacy 
of these mechanisms in preventing brain swelling depend on how rapidly hyponatremia 
and resultant hypo-osmolality occurs. When hypo-osmolality develops at a rate that 
exceeds the brain’s ability to regulate its volume, severe brain edema results, potentially 
leading to neurological dysfunction and sometimes death. Hypo-osmolality is 
considered to be acute when it develops over 24–48 h54. 
 
The initial adaptive response is movement of fluid from the interstitial space into the 
cerebrospinal fluid (CSF) and from there into the systemic circulation55. This is followed 
by the extrusion of intracellular inorganic ions (sodium, potassium and chloride), which 
will cause osmotic movement of water extracellularly. This is mediated by the sodium-
potassium ATPase pump and is energy dependent53. Animal studies have shown that 
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this process is initiated within thirty minutes of induced hyponatremia and reaches its 
maximum by three hours54.The second phase of the adaptive response involves the 
extrusion of intracellular organic solutes – mainly amino acids53,54. This phase takes 
longer to come into effect and is more useful for combatting chronic hyponatremia. The 
extrusion of these osmolytes is sustained for as long as hyponatremia persists53. 
 
There is evidence that age may influence the ability of the brain to adapt to 
hyponatremia and hypoosmolality in older children and adults56,57. The ratio of brain 
volume to skull vault size is higher in children due to the fact that the human skull does 
not attain full size until adulthood, although brain development is complete by six years 
of age56,57. In addition, brain water content is more than two-and-a-half times higher in 
the paediatric population56. The volume of CSF in adult brains is more than 10% greater 
than that in paediatric patients. This higher CSF volume allows for more space in which 
the brain can expand56. There is therefore less room for expansion of the paediatric 
brain in the skull than there is in adults. In addition to these physical factors, the 
paediatric brain has much less sodium-potassium-ATPase activity and higher 
intracellular concentration of sodium than adults, resulting in a steeper osmotic gradient 
during hyponatremia56,57. These studies focused on older children, whether neonates 
have these limitations in adapting to hyponatremia and hypo-osmolality is unclear but a 
possibility. 
  
As mentioned earlier, during hypoxic-ischemic injury of the brain, there is failure of 
transcellular ion pumps, disruption of ionic gradients and cell death caused by cytotoxic 
edema as well as apoptosis. Since these ion pumps are important in the regulation of 
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brain cell volume, the adaptive response to hyponatremia, is severely blunted by 
hypoxia58,59.  This results in worsening of brain edema and increases mortality59. 
Furthermore, it has been found that in patients with hyponatremic encephalopathy 
hypoxemia is a common finding and plays an important role in the eventual outcome. 
Two mechanisms have been proposed; respiratory depression secondary to brain 
edema and neurogenic pulmonary edema60. This suggests the possibility of a vicious 
cycle where the two pathologies have an additive adverse effect on the brain, greater 
than if either occurred alone, with a resultant increase in mortality. 
 
4.6.3   NEUROLOGIC OUTCOME FOLLOWING HYPONATREMIA 
 
Neuro-protective strategies usually include maintaining serum sodium levels within 
normal limits. Studies performed on adults, have shown adverse effects of dysnatremia 
on neurologic outcome 61-63 These studies however looked at disease entities more 
common in the adult population, namely strokes, sub-arachnoid haemorrhages and 
traumatic brain injuries. Very few studies have been done on the paediatric population.  
 
Al-Zahraa et al64. carried out an analysis on 72 children, including 14 neonates, who 
were admitted for neurologic pathologies in a tertiary hospital. They were divided into 3 
groups according to the serum sodium on admission – normal, mild deficit and 
moderate to severe deficit. The duration of stay of each patient in hospital was recorded 
and they were examined for the presence or absence of persistent neurologic deficits 
before their discharge and during follow-up visits. When analyzed according to the 
serum sodium grouping, the hospital stay was shortest for those with normal serum 
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sodium on admission. In terms of long term sequelae, the majority of patients (88.6%) 
with normal serum sodium on admission recovered completely. All those who had a 
mild deficit had neurodevelopmental sequelae, while all those with moderate to severe 
deficit were severely incapacitated, with 4 of them dying. The authors also found a 
significant inverse ‘dose–response relationship’ between the degree of hyponatremia 
and duration of hospital stay. They however emphasized that the group of patients that 
stayed longest contained a disproportionate number of conditions which tend to carry 
poor prognosis and hence longer stay. The serum sodium could have been an 
epiphenomenon reflecting severity of the children’s underlying diagnosis64. 
 
Mcjunkin et al. studied a group of 127 children admitted with La Crosse encephalitis, a 
mosquito-borne disease, investigating the clinical manifestations and clinical course. 
They assessed factors associated with in-hospital clinical deterioration, which occurred 
in 13 (11%) of the children. They found that in the patients with in-hospital deterioration, 
the nadir serum sodium level during hospitalization was slightly lower than in those 
without deterioration65. 
 
Sporadic case reports of symptomatic dilutional hyponatremia secondary to poor 
feeding practices of infants, appeared in the 1980s.They were typically 3-6 months of 
age presenting with an acute neurological syndrome characterized by generalized tonic-
clonic seizures, some lasting for several hours, apnoea or respiratory failure requiring 
ventilation in nearly half of the affected infants. Plasma sodium was usually below 
120mmol/L and readily correctable. The neurological disturbances resolved promptly 
and these infants had good outcomes66. 




In 1989, Vanapruks et al published case reports on 2 previously healthy neonates who 
had been fed dilute formula and excessive water and developed severe hyponatremia 
with seizures. The serum sodium was 117mmol/L in one and 116mmol/L in the other. 
One was given 5% hypertonic saline, while the other was only fluid-restricted. The 
serum sodium normalized for both and no further seizures occurred67. Bruce et al also 
published 2 case reports in 1997 on two infants, also presenting with convulsions 
following water intoxication at home. Following saline infusions, these infants recovered 
completely with no sequelae68. 
 
The few studies reporting on hyponatremia in neonates with perinatal asphyxia mainly 
looked at the incidence of hyponatremia and did not analyze its impact on neurologic 
outcome24,25. Gupta et al carried out a prospective case controlled study to determine 
the incidence of renal failure in asphyxiated neonates and to correlate severity and type 
of renal failure with Apgar score and HIE grading of the neonates. It was observed that 
babies with asphyxia had significantly higher incidence of hyponatremia than healthy 
controls. In addition to oliguria and abnormal renal sonographic scan, hyponatermia was 
noted to be an ominous signs predicting mortality in this study23.  
 
The data appears to be conflicting, with some studies showing no impact while others 
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5. AIMS /OBJECTIVES OF THE STUDY 
 
Primary objectives: 
1. To determine if there is an association between hyponatraemia in neonates with 
HIE who underwent therapeutic hypothermia and neurodevelopmental outcome 
at 12 months of age. 
2. To determine the association of hyponatraemia with severity of HIE in the 
neonatal period. 
Secondary objective 





This is a retrospective descriptive study conducted at the Tygerberg Children’s Hospital, 
Department of Paediatrics & Child Health, Stellenbosch University. The data was 
initially prospectively collected on infants who underwent therapeutic hypothermia for 
HIE from 2008 to 201169. 
 
6.1 INCLUSION CRITERIA 
 Infants who met the criteria for Therapeutic hypothermia (as outlined below) 
 Infants who had serum sodium levels done on three consecutive days during 
their therapeutic hypothermia treatment. 
 Infants who were followed up after discharge at 12 months of age. 





 Infants without follow-up assessment at 12 months, including those who died. 
 
The selection criteria that were used for therapeutic hypothermia: 
A. Infants ≥ 36 completed weeks gestation with at least one of the following:  
o Apgar score ≤ 7 at 10 minutes.  
o Continued need for resuscitation, including endotracheal or mask 
ventilation, at 10minutes after birth.  
o Acidosis within 60 minutes of birth (defined as any occurrence of umbilical 
cord, arterial or capillary pH < 7.00.  
o Base deficit ≥ 16mmol in umbilical cord or any blood sample (arterial, 
venous or capillary) within 60 minutes of birth.  
B. Infants who met criteria (A) were assessed for whether they met the neurological 
abnormality entry criteria for therapeutic hypothermia: 
o Altered state of consciousness (reduced or absent response to 
stimulation)  
o Abnormal primitive reflexes  
o Abnormal tone (focal or general hypotonia, or flaccidity)  
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For selection for cooling, modified Sarnat (moderate/severe) or an HIE Thompson score 
of 10 was used as a cut off for selection for cooling. 
 
Exclusion criteria for therapeutic hypothermia were: 
• Infants likely to require surgery during the first 3 days after birth.  
• Co-existent major congenital abnormalities such as those suggestive of 
chromosomal anomalies or other syndromes that included brain 
malformations.  
• Outborn infants (from primary or secondary level hospitals within Tygerberg 
Hospital’s drainage area), that could not reach the treatment center within 6-8 
hours of delivery.  
 
6.2. TYGERBERG CHILDREN’S HOSPITAL THERAPEUTIC HYPOTHERMIA     
       PROTOCOL 
 
Cooling was started as soon as possible after resuscitation was completed, ideally 
within 6 hours of birth. Rectal temperatures were monitored with rectal probes and 
cerebral function monitoring/amplitude integrated electroencephalogram (CFM/ aEEG) 
commenced at the beginning of cooling (where available). The Tecotherm cooling 
system guidelines were followed. The initial mattress temperature was set to 28ºC and 
adjusted according to response. A comprehensive cooling booklet was maintained for 
each neonate showing cooling starting time, target stop date (72 hours from start), initial 
temperature and serial rectal temperatures aiming for 33-34 ºC (whole body cooling). 
For sedation the following drugs were used: 
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 Phenobarbitone 10-20mg/kg (could be repeated up to 40mg/kg), 
 Lorazepam (Ativan) 0.05mg-0.1mg/kg/dose, 
Morphine 50mcg/kg slow IV bolus over 10 minutes, then 50mcg/kg bolus 6hourly 
or infusion at 8mcg/kg/hour. 
 The doses would be adjusted according to response. 
 
Rewarming: 
Cooling was stopped 72 hours from the time of initiation. The rate of rewarming 
was not to exceed 0.5ºC / hour. 
 
6.2.1 FLUID MANAGEMENT DURING COOLING 
 
Neonates were kept nil by mouth during the cooling period. The total fluid intake was 
restricted to 50ml/kg/day on admission to ICU and only potassium-free solutions were 
used (10% Neonatalyte®). Depending on the renal function and urine output, fluid could 
further be restricted. For urine output less than 1ml/kg/hr, furosemide (1-2mg/kg 
intravenously) would be considered as needed. 
 
Electrolytes were monitored and corrected as needed. The fluid restriction was released 
if the serum sodium, renal function and urine output were normal. For hyponatremia 
(serum sodium less than 135mmol/L), a 5% hypertonic saline solution was used for 
correction intravenously, at a rate that did not exceed 0.5mmol/hr. 
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6.3 METHOD OF DATA COLLECTION 
 
6.3.1 SERUM SODIUM 
 
Each patient received a booklet at the start of cooling, where daily records of serum 
electrolytes and other parameters were kept for the duration of the cooling and re-
warming period. For the purpose of this analysis, data were obtained from these cooling 
booklets as well as from daily clinical notes in patients’ files and from the hospital’s 
laboratory system (for incomplete data).  
 
6.3.2   NEURODEVELOPMENTAL ASSESSMENT  
 
After completion of cooling, patients were discharged from the ICU to neonatal wards 
and eventually discharged home. They were followed up by a neurodevelopmental 
specialist. Neurodevelopmental assessment was done at 12 months of age, using the 
Bayley-III Screening Test. The data obtained from these follow-up visits was stored in a 
database. For the purpose of this analysis, data obtained from these visits will be used 
and augmented with data from patient records. 
 
6.3.2.1    BAYLEY-III SCREENING TEST 
 
The Bayley-III Screening Test is used to assess the cognitive, language, and motor 
functioning of infants and young children between 1 month and 42 months of age. 
The test items are a subset of the cognitive, language, and motor items of the Bayley 
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Scales of Infant and Toddler Development, 3rd edition. The screening tool is used to 
determine if further, more comprehensive evaluation is needed. The child’s performance 
is scored on the basis of a risk category classification: competent, emerging, or at risk.  
 
CLASSIFICATION DEFINITION 
Competent Child is considered at low risk for 
developmental delay and in most cases 
does not need further evaluation. 
Emerging Child has some risk for developmental 
delay, but further evaluation is made on 
the basis of other information collected. 
Can monitor development or refer for 
further evaluation. 
At risk Child is most likely in need of further 
evaluation to determine need for early 
intervention. 
TABLE 2: Definitions of BSID-III Screening Classification70 
 
In this study the terms competent, emerging and at risk were used to refer to the above 
performance categories. 
 
6.4  STATISTICAL ANALYSIS 
 
Each infant had serum sodium levels measured in the laboratory on three consecutive 
days (day 1 – day 3) during TH. Hyponatremia was defined as a serum sodium less 
than 135mmol/L and hypernatremia was defined as a serum sodium more than 
145mmol/L. Since the majority of patients' sodium levels were between 130 and 134 
mmol/L and too few infants had hyponatremia levels below 130 mmol/L, we determined 
the frequency or number of hyponatremic episodes on the three consecutive days of 
cooling. This approach increased the data points to 63 (3 x 21), giving us some 
statistical power. Out of the three serum sodium levels recorded per patient, the number 
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of times each neonate was hyponatremic or hypernatremic was noted.  
 
This study seeks to determine if there is any association between the number of times a 
neonate was hyponatremic (0-3) and the neurodevelopmental outcomes at 12 months 
of age (competent, emerging and at risk) for the patients who survived. We also 
ascertained the relationship between the grade of HIE and hyponatremia. The three 
variables (neurodevelopment outcome, degree of HIE, number of hyponatremic 
episodes) represents categorical data hence the association between them was 
analysed using non-parametric methods - Kendall’s tau-b and Spearman ranked order 
(rho) correlation coefficients. The associations between the following variables were 
measured: 
o Number of hyponatremic episodes and neurodevelopmental outcome  
o Number of hyponatremic episodes and HIE grade  
o HIE grade and neurodevelopmental outocome 
The calculations were done using IBM SPSS Statistics 22 software.  
 
Sample size determination  
A sample size of 48 achieves 80% power to detect a difference of 0.30000 between the 
null hypothesis correlation of 0.00000 and the alternative hypothesis correlation of 
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7.  RESULTS 
 
The patient records yielded 100 patients who were potential candidates for the study 
from 2008 to 2011.  Of these patients: 
 
• twenty-eight (28) patients were never seen post discharge. 
• seventeen (17) patients died before 12 months  
• Fifty-five (55) patients had post discharge follow-up: 
  Fifty patients were followed up at 12 months  
  Five patients were seen before 12 months:  
50 patients were included in this study. These are patients who were seen at 12 months 
follow-up. 
 
7.1.   DESCRIPTIVE STATISTICS (PERINATAL PERIOD) 
 
Out of 50 patients analyzed, 21/50 (42%) had hyponatremic episodes while the rest 
(29/50 [58%]) were normonatremic. Of the hyponatremic infants, 10/21 (47.62%) were 
male while the rest were female (52.38%). The mean birth weight of hyponatremic 
infants was 3032g and the average pH within the first hour of life was 7.08 (cord sample 
or neonatal-derived). Six of the hyponatremic infants (28.57%) had seizures detected by 
aEEG during the 3days of TH. Of the normonatremic infants, the majority were male 
(24/29) with only 5 females. The average birth weight of these infants was 3222g and 
the average pH was 7.02. Fifteen of these infants (51.72%) had seizures (on aEEG) in 
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the first few days of life. This is summarized in table 3. The distribution of HIE grades 
among hyponatremic and normonatremic infants is also shown. Hyponatremic infants 
constituted the majority (6/7;85.71%) of those with severe HIE as compared to 
normonatremic infants. The differences of the other variables between hyponatremic 









MALES 10 (47.62%) 24 (82.76%) 34 
FEMALES 11 (52.38%) 5 (17.24%) 16 














SEIZURES 6 (28.57%) 14 (48.28%) 20 
HIE GRADE  1 
                      2 
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7.1.1    HIE grades 
Forty-seven (47/50) of the patients had their HIE grades documented. The frequency of 




Figure 1 Frequency bar chart of HIE grades  
 
7.1.2 SERUM SODIUM LEVELS 
 
The patients had serial serum sodium levels measured on the first three consecutive 
days of life while undergoing therapeutic hypothermia. Of the fifty analysed patients, 
21/50 (42%) had hyponatremia and the rest were normonatremic 29/50 (58%). 
Of the hyponatremic patients; 
• 14/21 had sodium between 130 - 134 mmol/L.   


















Frequency bar chart of HIE grades 
Stellenbosch University  https://scholar.sun.ac.za
36 
 
The distribution of serum sodium levels for each of the three consecutive days is shown 
on the boxplot (figure 2) and the dispersion was measured using the standard deviation 




Figure 2: Boxplot of Sodium levels for days 1 to 3. 
 
Hyponatremic infants tended to have a relatively high proportion with severe HIE grades 
compared to normonatremic infants. Of all the infants with HIE grade 1 (n = 22), 14 of 
them (63.64%) were normonatremic, while 6/7 (85.71%) of those with HIE grade 3 were 
hyponatremic. Twenty-nine percent (6/21) of hyponatremic infants had HIE grade 3 
compared to 3% (1/29) in the normonatremic infants. A hyponatremic infant was 8 times 
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more likely to have an HIE grade of 3 than a normonatremic infant (RR = 8.29) as 
shown in table 4 and figure 3 below.  
 
 
Figure 3: Frequency of different HIE grades in normonatremic and hyponatremic          
               infants. 
 
 
HIE GRADE NORMONATREMIC INFANTS HYPONATREMIC INFANTS Rel. Risk 
1 14 8 0.79 
2 12 6 0.69 
3 1 6 8.29 
Undocumented 2 1  
 
Table 4: Frequency of HIE Grades in hyponatremic and normonatremic infants with 






















Frequency of different HIE grades in normonatremic and 
hyponatremic infants.
NORMONATREMIC INFANTS HYPONATREMIC INFANTS




The frequency of hyponatremic episodes reflects how many days out of the three during 
TH an infant had hyponatremia. The majority of the hyponatremic infants had 
hyponatremia on one day out of three. Only 3/21 had hyponatremia on all three days, as 




Figure 4: Frequency bar chart of number of hyponatremic episodes 
 
7.1.3 NEURODEVELOPMENTAL OUTCOME 
 
Neurodevelopmental assessment was done using the Bayley III Screening tool. The 
frequency bar chart below shows the distribution of neurodevelopmental functional 



















Number of Hyponatremic Episodes 
Frequency bar chart of number of hyponatremic 
episodes 
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five (70%) were assessed as competent, nine (18%) as emerging and six (12%) as at 




Figure 5 Frequency bar chart of neurodevelopmental functional status at 12 months 
 
Of all the neonates who had been hyponatremic, 15/21 (71.43%) were assessed as 
“Competent” at 12 months, while 3/21 (14.29%) were assessed as “Emerging” and 3/21 
as “At risk”. Of those who had been normonatremic, 20/29 (68.97%) were assessed as 
“Competent”, 6/29 (20.69%) as “Emerging” and 3/29 (10.34%) “At risk”.The difference 
between proportions of outcome in hyponatremic and normonatremic infants is not 
















At risk Emerging Competent
Neurodevelopment outcome at 12 months





Figure 6 Neurodevelopmental outcome in Hyponatremic Vs Normonatremic 
               Neonate 
 
7.2.   ANALYTIC STATISTICS  
 
The research question is to investigate if there is any association between: 
1. Neurodevelopmental outcome at 12 months of age and hyponatremia.  
2. Hyponatremia and HIE grade  
Two statistical tests (Kendall’s tau b and Spearman’s ranked order) were used to 
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assess for the presence of the above-mentioned relationships. The results were 
reproducible for both statistical tests (Table 3). 
 
CORRELATED VARIABLES  TEST STATISTIC  
CORRELATION 
COEFFICIENTS SIGNIFICANCE 
Number of hyponatremic 
episodes AND 
Neurodevelopmental 
functional status   
Kendall's tau_b 0.018 0.444 
Spearman's rho 0.021 0.443 
        
HIE grade AND 
Neurodevelopmental 
functional status at 12 months  
Kendall's tau_b 0.123 0.184 
Spearman's rho 0.13 0.193 
        
Number of hyponatremic 
episodes and HIE grade  
Kendall's tau_b 0.224 0.024 
Spearman's rho 0.25 0.025 
 
Table 5: Cross-tabulation for functional status vs number of hyponatremic       
               episodes 
 
There was no association between neurodevelopmental functional status at 12 months 
and number of hyponatremic episodes in the first 3 days of life (p = 0.444). There was 
significant positive correlation between number of hyponatremic episodes and HIE 
grade with both Kendall’s tau_b and Spearman’s rho test (p = 0.024 and p 0.025 
respectively). We found no association between HIE grade and neurodevelopmental 
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8.  DISCUSSION 
 
The primary objective of the study was to assess for an association between 
hyponatremia in neonates with HIE who underwent cooling, and neurodevelopmental 
outcome at 12 months of age. The secondary objective was to determine the 
association of hyponatraemia with severity of HIE in the neonatal period. Our study 
showed no association between hyponatremia and outcome at 12 months. Studies 
done previously showed conflicting results, with some showing complete recovery 
following hyponatremic encephalopathy66-68, while others showed an increased risk of 
mortality and morbidity56,64,65. The reports of good outcomes were however of patients 
with no pre-existing comorbidities. We found a positive correlation between HIE grade 
and number (frequency) of hyponatremic episodes; neonates with severe HIE had a 
higher frequency of hyponatremia. This is in keeping with previous studies that showed 
that the degree of hyponatremia was directly proportional to the severity of HIE24.  
 
Hypertonic saline was administered to hyponatremic patients in this study. This may 
have had an impact on the results, especially since the majority (14/21) of them had 
mild hyponatremia (serum sodium 130 – 134mmol/L). Moreover, the serum sodium 
levels were taken at 24 hour intervals. Significant deviations might have been noted if 
levels were checked more frequently. The implementation of TH has been shown to 
modify the predictive value of variables that have previously been shown to be useful in 
predicting neurodevelopmental outcome after HIE20. This could be another reason why 
there was no association found between hyponatremia and outcome in this study.  
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Variables that had been shown to affect neurodevelopmental outcome following 
perinatal asphyxia pre-cooling include APGAR scores, pH within 1 hour of birth, base 
deficit, HIE grade, birth weight, presence/absence of seizures and aEEG 
abnormalities19. In this study, a significant difference between hyponatremic and 
normonatremic infants was noted in the distribution of HIE grades -  85.7% of those with 
grade 3 being hyponatremic as compared to 57.1% of those with grade 1. There was 
also a significant difference in the occurrence of seizures, the majority of infants who 
had seizures (15/21;71.4%) were normonatremic and only 6/21 (28.6%) had 
hyponatremia. Mean birth weight was lower in the hyponatremic group. A larger sample 
size would have allowed for multi-variate analysis in order to assess for potential 
confounders. 
 
We also looked for an association between HIE grade and neurodevelopmental 
outcome at 12 months of age. No association was found between these two variables 
although previous studies have shown HIE grade to be predictive of outcome19. This 
again could be due to the fact that these patients underwent therapeutic hypothermia, 
altering the predictive value of HIE grade. Selection bias was also a possibility as only 
those with complete data present were studied. 
 
A strength of the study is that it analyzed a uniform sample with sodium measurements 
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Future research perspectives: 
 
A statistically powered study allowing us to do more subpopulation analysis would yield 
more information. This may potentially need a multi-center conducted study. This would 
allow stratification according to hyponatremia severity as well as multivariate analysis. 
 
 
9. CONCLUSION  
 
There was no association between neurodevelopmental outcome at 12 months and 
number of hyponatraemic episodes in the first week of life in neonates with HIE who 
underwent therapeutic hypothermia. There was significant association between number 
of hyponatremic episodes and HIE grade. We found no association between 
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